Hepatitis Monthly

Published by: Kowsar

HCV NS3 Blocking Effect on IFN Induced ISGs Like Viperin and IL28 With and Without NS4A

Zahra Khanlari 1 , Farzaneh Sabahi 1 , * , Seyed Younes Hosseini 2 and Mostafa Ghaderi 1
Authors Information
1 Department of Medical Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
2 Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: June 01, 2014, 14 (6); e17822
  • Published Online: June 8, 2014
  • Article Type: Research Article
  • Received: January 25, 2014
  • Revised: March 9, 2014
  • Accepted: April 13, 2014
  • DOI: 10.5812/hepatmon.17822

To Cite: Khanlari Z, Sabahi F, Hosseini S Y, Ghaderi M. HCV NS3 Blocking Effect on IFN Induced ISGs Like Viperin and IL28 With and Without NS4A, Hepat Mon. 2014 ; 14(6):e17822. doi: 10.5812/hepatmon.17822.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244(4902): 359-62[PubMed]
  • 2. Raney KD, Sharma SD, Moustafa IM, Cameron CE. Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J Biol Chem. 2010; 285(30): 22725-31[DOI][PubMed]
  • 3. World Health Organization . . Media Centre,Hepatitis C. 2012;
  • 4. Freundt EC, Lenardo MJ. Interfering with interferons: Hepatitis C virus counters innate immunity. Proc Natl Acad Sci U S A. 2005; 102(49): 17539-40[DOI][PubMed]
  • 5. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992; 16(2): 293-9[PubMed]
  • 6. Short J. Viral evasion of interferon stimulated geneg. Bioscience Horizone. 2009; 2(2): 212-24[DOI]
  • 7. Fitzgerald KA. The interferon inducible gene: Viperin. J Interferon Cytokine Res. 2011; 31(1): 131-5[DOI][PubMed]
  • 8. Mattijssen S, Pruijn GJ. Viperin, a key player in the antiviral response. Microbes Infect. 2012; 14(5): 419-26[DOI][PubMed]
  • 9. Seo JY, Yaneva R, Cresswell P. Viperin: a multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe. 2011; 10(6): 534-9[DOI][PubMed]
  • 10. Chan YL, Chang TH, Liao CL, Lin YL. The cellular antiviral protein viperin is attenuated by proteasome-mediated protein degradation in Japanese encephalitis virus-infected cells. J Virol. 2008; 82(21): 10455-64[DOI][PubMed]
  • 11. White LK, Sali T, Alvarado D, Gatti E, Pierre P, Streblow D, et al. Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff. J Virol. 2011; 85(1): 606-20[DOI][PubMed]
  • 12. Khaiboullina SF, Rizvanov AA, Holbrook MR, St Jeor S. Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression. Virology. 2005; 342(2): 167-76[DOI][PubMed]
  • 13. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology. 2005; 42(3): 702-10[DOI][PubMed]
  • 14. Wang S, Wu X, Pan T, Song W, Wang Y, Zhang F, et al. Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33. J Gen Virol. 2012; 93: 83-92[DOI][PubMed]
  • 15. Jouan L, Melancon P, Rodrigue-Gervais IG, Raymond VA, Selliah S, Boucher G, et al. Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease. J Hepatol. 2010; 52(2): 167-75[DOI][PubMed]
  • 16. Romano KP, Laine JM, Deveau LM, Cao H, Massi F, Schiffer CA. Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease. J Virol. 2011; 85(13): 6106-16[DOI][PubMed]
  • 17. Tomei L, Failla C, Santolini E, De Francesco R, La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol. 1993; 67(7): 4017-26[PubMed]
  • 18. Hosseini SY, Sabahi F, Moazzeni SM, Modarressi MH, Saberi Firoozi M, Ravanshad M. Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes. Hepat Mon. 2012; 12(8)[DOI][PubMed]
  • 19. Conceicao TM, El-Bacha T, Villas-Boas CS, Coello G, Ramirez J, Montero-Lomeli M, et al. Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response. J Infect. 2010; 60(1): 65-75[DOI][PubMed]
  • 20. Berenguer M, López-Labrador FX. Boceprevir in the treatment of chronic hepatitis C virus infection. Virus Adaptation and Treatment. 2011; 3: 7-17
  • 21. Dubuisson J, Penin F, Moradpour D. Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol. 2002; 12(11): 517-23[PubMed]
  • 22. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A. 1998; 95(26): 15623-8[PubMed]
  • 23. Helbig KJ, Eyre NS, Yip E, Narayana S, Li K, Fiches G, et al. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology. 2011; 54(5): 1506-17[DOI][PubMed]
  • 24. Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, et al. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol. 2008; 82(4): 1665-78[DOI][PubMed]
  • 25. Eisa ZM. Effect of protease and helicase mutations on HCV NS3 activity. Saudi J Biol Sci. 2011; 18(2): 195-200[DOI][PubMed]
  • 26. Heim MH, Moradpour D, Blum HE. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol. 1999; 73(10): 8469-75[PubMed]
  • 27. Kaukinen P, Sillanpaa M, Kotenko S, Lin R, Hiscott J, Melen K, et al. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol J. 2006; 3: 66[DOI][PubMed]
  • 28. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005; 102(8): 2992-7[DOI][PubMed]
  • 29. Ochi H, Maekawa T, Abe H, Hayashida Y, Nakano R, Imamura M, et al. IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations. J Gen Virol. 2011; 92: 1071-81[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments